Pharmaceutical Industry Reports postpartum depression drug market

REPORT DESCRIPTION Postpartum Depression Drug Market – Key Players Sage Therapeutics Sun Pharmaceutical Industries Cipla Limited Intas Pharmaceuticals Mylan N.V Anikem Laboratories Shionogi & Co Antidepressant drugs refusals by the U.S. Food and Drug Administration (U.S FDA) are expected to be a major restraint in growth of the postpartum depression drug market over the forecast period. For instance, in April 2018, the U.S FDA refused New Drug Application of Alkermes plc.’s drug candidate ALKS 5461 which is to be administered orally. Get More Inf @ https://www.coherentmarketinsights.com/ongoing-insight/postpartum-depression-drug-market-2258

Pharmaceutical Industry Reports postpartum depression drug market | Page 4